The sixth Aids Symposium for MUSC students will be held from Nov. 12-14 in the Basic Science Building Auditorium.

This symposium, organized as a continuing education professional meeting and as an integral part of the curriculum for medical, dental and physician assistant students, as well as graduate students in the microbiology program, offers students the opportunity to participate in a high caliber multi-disciplinary meeting which presents a broad overview of the scientific and social problems raised by the AIDS epidemic.

Two distinguished speakers will participate in this year’s symposium. Margaret Johnston, Ph.D., scientific director of the International AIDS Vaccine Initiative, based at the Rockefeller Foundation, Washington, D.C., will deliver the opening lecture at 5 p.m. Wednesday, Nov. 12, entitled “AIDS: The Life and Death of HIV.”

Johnston will present a second lecture at 11 a.m. on Thursday, Nov. 13, entitled “Global Strategies to Combat the AIDS Epidemic.”

The second invited speaker, Michael Grieco, M.D., is professor of clinical medicine at Columbia University College of Physicians & Surgeons, chief of the Division of Allergy, Clinical Immunology and Infectious Diseases, and director of the AIDS Center Program at St. Luke’s—Roosevelt Medical Center, New York. He will present two lectures on Thursday, Nov. 13. At 9:30 a.m. Grieco will speak on “HIV and the Immune System,” and at 1 p.m. he will deliver the Bristol-Myers Squibb Lecture on “Management of HIV Positive and AIDS Patients.”

The symposium also includes panel discussions on “HIV Infection: The Patient’s Perspective” (Thursday, Nov. 13, 8 a.m.), and on “AIDS and the Health Care Worker” (Friday, Nov. 14, 8 a.m.), a Clinico—Pathological Conference on the “Clinico- Pathological Aspects of AIDS” (Thursday, Nov. 13, 2 p.m.), and closes with a discussion on “Aspects of AIDS Prevention,” led by James L. Sacco, of the Centers for Disease Control, Atlanta.

The 1997 symposium is supported by the Alpha chapter of the Alpha Omega Alpha Honor Medical Association, MUSC’s Office of Continuing Medical Education and Department of Microbiology and Immunology, Bristol-Myers Squibb, and Glaxo Wellcome, Inc.